[Ketoconazole--a change in antimycotic therapy?].
D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003881:Dermatomycoses / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D007654:Ketoconazole; D014009:Onychomycosis / Q000188:drug therapy; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D014008:Tinea Pedis / Q000188:drug therapy; D014010:Tinea Versicolor / Q000188:drug therapy
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole
Ketoconazol--Wende in der antimykotischen Therapie?